D-Wave's Record Bookings and Twin Federal Grants Collide With a Laptop-Based Quantum Challenge

D-Wave Quantum reports record $33.4M bookings and secures $100M CHIPS Act funding, but a scientific paper challenges its quantum advantage claims, causing stock volatility.

D-Wave Quantum enters a pivotal week with a dizzying mix of signals: a record order pipeline, two freshly confirmed government funding streams, and a scientific paper that claims a laptop can replicate part of the company's flagship quantum demonstration. The stock, which had surged 42% over the previous week, pulled back on Wednesday, sliding to €22.77 in European trading after touching €23.53 earlier in the session. On the New York exchange, the intraday range stretched from $26.08 to $27.62 on volume exceeding 8.5 million shares.

The scientific dispute stems from a study published in Science by researchers at the Flatiron Institute and Boston University. They showed that tensor-network methods combined with belief propagation — running on classical hardware, including a laptop in early calculations — could simulate certain spin-glass problems that D-Wave had marketed as exclusively solvable by its quantum annealing systems. D-Wave's chief executive Alan Baratz pushed back, arguing that the classical simulation did not cover all geometries, observables, system sizes, or coupling strengths explored in the original experiment. The company specifically contends that the approach fails for strongly coupled three-dimensional spin glasses on cubic and diamond lattices, as well as for higher-dimensional biclique problems.

The noise from the academic row has overshadowed a remarkable — if uneven — financial picture. In its fiscal first quarter of 2026, D-Wave reported record bookings of $33.4 million, a staggering jump from $1.6 million a year earlier. Yet actual recognized revenue came in at just $2.9 million, down from $15 million in the prior-year period. For the full fiscal year 2025, revenue reached $24.6 million, up 179% from the year before, while the net loss widened to $355 million. The chasm between bookings and revenue highlights the difficulty of converting long-term quantum hardware contracts into near-term cash flow — a challenge the company will need to address head-on.

On the funding front, D-Wave has secured two overlapping government commitments. The first is the second year of the SQFab project, awarded through the U.S. Microelectronics Commons Initiative’s NORDTECH hub. More than $25 million in total funding flows to four programs in this round; D-Wave's portion, channeled through its subsidiary Quantum Circuits LLC, targets improved materials and scalable fabrication methods for superconducting qubits, including advances in quantum circuits, qubit control, and error correction. The second is a preliminary memorandum of terms signed on May 21 with the U.S. Department of Commerce, under the CHIPS and Science Act, listing D-Wave for $100 million in incentives. That award is contingent on improvements in qubit count, error rates, and coherence through dielectric material optimization and advanced packaging, and requires the government to take a non-controlling minority stake in the company.

The twin grants reinforce the same technical roadmap: superconducting qubit technology, material engineering, and packaging. But they also raise execution risk. Investors must judge whether D-Wave can translate the SQFab and CHIPS milestones into measurable hardware progress — and whether the $100 million Commerce pledge will ultimately materialize amid congressional and bureaucratic hurdles.

The competitive landscape remains intense. Quantinuum, a direct rival, is preparing an initial public offering at an expected valuation of roughly $12.7 billion. IonQ, another competitor, draws investor attention with stronger revenue growth and a debt-free balance sheet. Against that backdrop, Wall Street remains broadly bullish on D-Wave: ten of eleven analysts covering the stock rate it a buy, with a consensus price target of $36.11, about 30% above current levels.

All these threads — the scientific controversy, the bookings-revenue gap, the government grants, and the competitive field — converge on June 1, when D-Wave hosts its first investor day at the New York Stock Exchange. Management will have to explain how record orders will eventually become sustainable revenue, and directly address whether the Flatiron study undermines the company's quantum advantage claims. The presentation may ultimately determine whether the recent stock retreat is a temporary bump or the beginning of a broader reassessment.